If there were ever a time and place to reverse the saying “keep your friends close and your enemies closer,” it would be Taiwan, August 2022. As pressure mounts from across the Strait, let’s invite back some four million visitors – sellers, buyers, investors, investment suitors, free-spending tourists, caregivers, activists, and students – between now…
Though domestic tourism is doing well outside Taiwan’s major cities, a lack of clarity on border reopening has left businesses dependent on the international market in limbo. For the past two-and-a-half years, Taiwan’s travel industry has grappled with an uncomfortable truth: Its reliance on international visitors has become a liability amid broad public support for…
One of the key lessons of the ongoing COVID-19 pandemic for both governments and societies is the importance of strengthening and promoting public health systems and initiatives to eradicate infectious diseases and safeguard populations. Taiwan, whose pandemic management has arguably been among the best in the world, has also made significant strides in fighting illnesses…
Taiwan today finds itself facing a number of tough challenges, including the ongoing COVID-19 pandemic, climate change, increased U.S.-China competition, and, most recently, the war in Ukraine. For Taiwan’s central and local governments, industries, civil society, and the general public, meeting these challenges will require working together to increase Taiwan’s resiliency on several fronts. These…
For nearly four decades, Abbott has been making science-based nutrition products, innovative medical devices, diagnostics with advanced health technologies as well as branded generic medicines available to the people of Taiwan to help them live healthier and fuller lives. “Our 2030 Sustainability Plan is intentionally designing access and affordability into many of our life-changing technologies…
The island’s manufacturing and technological strengths and trove of medical data make it well positioned to assume a significant role in biotech development and healthcare supply chains, but to do so, it must first surmount some longstanding obstacles. In the last year, the world has become painfully aware of the importance of supply chains in…
More than two million doses of Medigen’s MVC-COV1901 have been administered domestically, but it has yet to gain traction internationally. Meanwhile UBI Pharma’s UB-612 is pending emergency-use authorization in Taiwan. Early in the coronavirus pandemic, Taiwan made a fateful decision: It would develop its own COVID-19 vaccines and make them a key part of its…
Since the pandemic began, Taiwan has developed several herbal formulas that traditional Chinese medicine doctors say are effective in treating COVID-19. The most prominent of these is Taiwan Chingguan Yihau (NRICM101), marketed under the name Respire Aid and developed by Taiwan’s National Research Institute of Chinese Medicine (NRICM). The treatment is made up of ten…
Given an exponential rise in locally transmitted COVID-19 case numbers (the vast majority of which have been mild or asymptomatic), Taiwan’s leaders have quickly begun working to develop a policy of “coexisting with the virus.” As during the initial outbreak of the pandemic in 2020, some fumbles have occurred as that policy coalesces, but once…
By Courtney Donovan Smith Taishang Factories Disrupted by COVID-19 Taiwanese manufacturers in China, particularly those based in Shanghai and neighboring Kunshan, have suffered plant closures and supply chain issues due to China’s “dynamic zero-COVID” policies and the extended lockdown of the Shanghai region, widespread disruptions to trucking within China, and delays at the port of…
